MSI-H Cancer Clinical Trials

8 clinical trials for MSI-H Cancer across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer — RECRUITING · PHASE2
• Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors. — RECRUITING · PHASE1
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors — RECRUITING · PHASE2
• Vascular Toxicities of Immune ChecKpoint Inhibitors : From Bed to Benchside — COMPLETED · NA
• Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search